151 related articles for article (PubMed ID: 8654565)
21. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
22. Block of non-L-, non-N-type Ca2+ channels in rat insulinoma RINm5F cells by omega-agatoxin IVA and omega-conotoxin MVIIC.
Magnelli V; Pollo A; Sher E; Carbone E
Pflugers Arch; 1995 Apr; 429(6):762-71. PubMed ID: 7603830
[TBL] [Abstract][Full Text] [Related]
23. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines.
Codignola A; Tarroni P; Clementi F; Pollo A; Lovallo M; Carbone E; Sher E
J Biol Chem; 1993 Dec; 268(35):26240-7. PubMed ID: 8253745
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of L- and non-L, non-N-type Ca2+ channels by basal and stimulated protein kinase C activation in insulin-secreting RINm5F cells.
Platano D; Pollo A; Carbone E; Aicardi G
FEBS Lett; 1996 Aug; 391(1-2):189-94. PubMed ID: 8706914
[TBL] [Abstract][Full Text] [Related]
25. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
Hewett SJ; Atchison WD
Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
[TBL] [Abstract][Full Text] [Related]
26. Simulations of active zone structure and function at mammalian NMJs predict that loss of calcium channels alone is not sufficient to replicate LEMS effects.
Ginebaugh SP; Badawi Y; Laghaei R; Mersky G; Wallace CJ; Tarr TB; Kaufhold C; Reddel S; Meriney SD
J Neurophysiol; 2023 May; 129(5):1259-1277. PubMed ID: 37073966
[TBL] [Abstract][Full Text] [Related]
27. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
28. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
[TBL] [Abstract][Full Text] [Related]
29. Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction.
Peers C; Johnston I; Lang B; Wray D
Neurosci Lett; 1993 Apr; 153(1):45-8. PubMed ID: 8390031
[TBL] [Abstract][Full Text] [Related]
30. A single non-L-, non-N-type Ca2+ channel in rat insulin-secreting RINm5F cells.
Magnelli V; Avaltroni A; Carbone E
Pflugers Arch; 1996 Jan; 431(3):341-52. PubMed ID: 8584427
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
Takamori M; Komai K; Iwasa K
Am J Med Sci; 2000 Apr; 319(4):204-8. PubMed ID: 10768604
[TBL] [Abstract][Full Text] [Related]
32. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.
Leveque C; Hoshino T; David P; Shoji-Kasai Y; Leys K; Omori A; Lang B; el Far O; Sato K; Martin-Moutot N
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3625-9. PubMed ID: 1314395
[TBL] [Abstract][Full Text] [Related]
33. Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.
Hajela RK; Huntoon KM; Atchison WD
Muscle Nerve; 2015 Feb; 51(2):176-84. PubMed ID: 24862203
[TBL] [Abstract][Full Text] [Related]
34. Binding of Lambert-Eaton myasthenic syndrome IgG to synaptosomal proteins does not correlate with an inhibition of calcium uptake.
Martin-Moutot N; Lang B; Newsom-Davis J; Seagar M
Neurosci Lett; 1995 Mar; 187(2):115-8. PubMed ID: 7783957
[TBL] [Abstract][Full Text] [Related]
35. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
36. Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist.
Tarr TB; Lacomis D; Reddel SW; Liang M; Valdomir G; Frasso M; Wipf P; Meriney SD
J Physiol; 2014 Aug; 592(16):3687-96. PubMed ID: 25015919
[TBL] [Abstract][Full Text] [Related]
37. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
[No Abstract] [Full Text] [Related]
38. Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent.
Hewett SJ; Atchison WD
Brain Res; 1992 Dec; 599(2):317-23. PubMed ID: 1363288
[TBL] [Abstract][Full Text] [Related]
39. Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome.
Nakao YK; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Mori M; Itoh M; Nagataki S
J Neurol; 1999 Jan; 246(1):38-44. PubMed ID: 9987712
[TBL] [Abstract][Full Text] [Related]
40. Interaction of synaptotagmin with voltage gated calcium channels: a role in Lambert-Eaton myasthenic syndrome?
David P; Martin-Moutot N; Leveque C; el Far O; Takahashi M; Seagar MJ
Neuromuscul Disord; 1993; 3(5-6):451-4. PubMed ID: 8186692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]